<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03943732</url>
  </required_header>
  <id_info>
    <org_study_id>FA-PNEU</org_study_id>
    <secondary_id>2019/14MAR/124</secondary_id>
    <nct_id>NCT03943732</nct_id>
  </id_info>
  <brief_title>Trial Measuring the Clinical Impact of the FilmArray® Pneumonia Panel in Critically Ill</brief_title>
  <acronym>FA-PNEU</acronym>
  <official_title>Randomized Trial Measuring the Clinical Impact of the FilmArray® Pneumonia, a Prospective Interventional Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>BioMérieux</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to measure how the use of Film-Array Pneumonia (FA-PNEU) on
      respiratory samples of adult patients suspected of acute care pneumonia in the intensive care
      unit of Saint-Luc University Hospital can accelerate / improve the initiation of the optimal
      antibiotic treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main objective of this trial is to confirm/attest/prove the following statement:

      The use of the FilmArray Pneumonia panel on respiratory samples of critically ill suspected
      with pneumonia, enables a faster microbiological pneumonia diagnosis and an improved
      therapeutic management of the patient.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 27, 2019</start_date>
  <completion_date type="Anticipated">May 20, 2020</completion_date>
  <primary_completion_date type="Anticipated">May 20, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <intervention_model_description>Open Randomized study, consecutive 2 weeks-period for observation group and study group</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Turn Around Time Treatment</measure>
    <time_frame>48 hours from arrival of the respiratory sample at the laboratory</time_frame>
    <description>Turn Around Time administration of optimal antimicrobial treatment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Performances FilmArray Pneumonia</measure>
    <time_frame>1 week from arrival of the respiratory sample at the laboratory</time_frame>
    <description>Microbiological performances FA-PNEU test versus routine microbiology testing</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Pneumonia</condition>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Respiratory samples are treated according to routine laboratory testing : culture, immuno assays</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Respiratory samples are treated according to routine laboratory testing : culture, immuno assays AND molecular testing (FilmArray PNEU) of the endotracheal aspirate sample 24 hours a day.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>FilmArray Pneumonia</intervention_name>
    <description>FilmArray Pneumonia testing of tracheal sample</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients 18 years, remaining at the intensive care of the Saint-Luc University
             Hospital

          -  Recently transferred from emergency care with Community acquired Pneumonia of grade 4
             suspicion

          -  With a Ventilation acquired Pneumonia suspicion

        Suspicion will be based on symptoms, clinical, biological and radiological criteria.

        Exclusion Criteria:

          -  Patients from whom no respiratory sample can be obtained

          -  Patients benefitting from palliative care

          -  Insufficient volume of the respiratory sample after routine testing to perform the
             FA-PNEU test.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexia VERROKEN</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cliniques universitaires St-Luc</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alexia VERROKEN, MD, PhD</last_name>
    <phone>+3227646766</phone>
    <email>alexia.verroken@uclouvain.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pierre-François LATERRE, MD, PhD</last_name>
    <email>pierre-françois.laterre@uclouvain.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cliniques Universitaires Saint-Luc</name>
      <address>
        <city>Bruxelles</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexia Verroken</last_name>
    </contact>
    <investigator>
      <last_name>Alexia Verroken</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 8, 2019</study_first_submitted>
  <study_first_submitted_qc>May 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 9, 2019</study_first_posted>
  <last_update_submitted>May 6, 2020</last_update_submitted>
  <last_update_submitted_qc>May 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pneumonia</keyword>
  <keyword>Molecular Testing</keyword>
  <keyword>Clinical impact</keyword>
  <keyword>FilmArray Pneumonia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

